Cytokinetics (CYTK) Receivables (2016 - 2024)
Historic Receivables for Cytokinetics (CYTK) over the last 9 years, with Q3 2024 value amounting to $244000.0.
- Cytokinetics' Receivables fell 9023.61% to $244000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $244000.0, marking a year-over-year decrease of 9023.61%. This contributed to the annual value of $1.3 million for FY2023, which is 77278.91% up from last year.
- Latest data reveals that Cytokinetics reported Receivables of $244000.0 as of Q3 2024, which was down 9023.61% from $834000.0 recorded in Q1 2024.
- In the past 5 years, Cytokinetics' Receivables registered a high of $51.8 million during Q4 2021, and its lowest value of $147000.0 during Q4 2022.
- Over the past 5 years, Cytokinetics' median Receivables value was $2.3 million (recorded in 2020), while the average stood at $5.1 million.
- Its Receivables has fluctuated over the past 5 years, first soared by 107237.56% in 2021, then plummeted by 9971.63% in 2022.
- Quarter analysis of 5 years shows Cytokinetics' Receivables stood at $4.4 million in 2020, then skyrocketed by 1072.38% to $51.8 million in 2021, then plummeted by 99.72% to $147000.0 in 2022, then skyrocketed by 772.79% to $1.3 million in 2023, then plummeted by 80.98% to $244000.0 in 2024.
- Its Receivables stands at $244000.0 for Q3 2024, versus $834000.0 for Q1 2024 and $1.3 million for Q4 2023.